Clinical trials: Citrate Adverse Reaction

Catheter-Related Infections, Citrate Adverse Reaction

DuraLock-C Catheter Lock Solution

• Terminated
• Age: 18 years and older
• Observational study
• Medical device

To evaluate the safety and performance of DuraLock-C 4.0%, 30.0%, and 46.7% for the maintenance of central venous catheter (CVC) patency in adult hemodialysis (HD) patients

Trial name

NCT04787926

Testing

Locking Solution

Where

France

Volunteers

17 people

Sponsor

Medical Components, Inc dba MedComp